...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Two big thank you’s
Reply New Message
Prev Message Back To Forum Threaded View Next Message

I have some spinout shares in my TFSA. Most however were spun out into my regular account. My thinking is I'll take the known tax risk than risk the TFSA penalties. If I were to look into it seriously I'll retain a CPA. Just my own personal view.

2 Recommendations
Reply New Message
Prev Message Back To Forum Threaded View Next Message
Share
Share
New Message
Please login to post a reply